Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""SQUAMOUS cell carcinoma"" wg kryterium: Temat


Tytuł:
Association between continuous cessation or reduction of drinking alcohol and improvement of multiple dysplastic lesions in patients with esophageal squamous cell carcinoma after endoscopic resection.
Autorzy:
Hori K; Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.; Department of Internal Medicine, Tsuyama Chuo Hospital, Tsuyama, Japan.
Katada C; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho Syhogoin Sakyo, Kyoto, 606-8507, Japan. .; Department of Real World Data Research and Development, Graduate School of Medicine, Kyoto University, 54 Kawaharacho Syhogoin Sakyo, Kyoto, 606-8507, Japan. .
Okada H; Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
Katagiri A; Department of Medicine, Division of Gastroenterology, Showa University Hospital, Tokyo, Japan.
Matsuo Y; Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan.
Yokoyama T; Department of Health and Promotion, National Institute of Public Health, Wako, Japan.
Yano T; Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
Suzuki H; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Shimizu Y; Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Furue Y; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
Nakanishi H; Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Koike T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takizawa K; Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.; Department of Endoscopy, Koyukai Shin-Sapporo Hospital, Hokkaido, Japan.
Hirao M; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Yoshii T; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Yamanouchi T; Department of Gastroenterology, Kumamoto Regional Medical Center, Kumamoto, Japan.
Kawakubo H; Department of Surgery, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan.
Kobayashi N; Department of Gastroenterology, Tochigi Cancer Center, Utsunomiya, Japan.
Shimoda T; Division of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Ochiai A; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
Ishikawa H; Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yokoyama A; Clinical Research Unit, National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan.
Muto M; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho Syhogoin Sakyo, Kyoto, 606-8507, Japan.
Pokaż więcej
Źródło:
Esophagus : official journal of the Japan Esophageal Society [Esophagus] 2024 Jan; Vol. 21 (1), pp. 31-40. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*
Esophageal Neoplasms*/pathology
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Cohort Studies ; Risk Factors ; Esophagoscopy
Czasopismo naukowe
Tytuł:
Usefulness of the aldehyde breath test for predicting metachronous recurrence in patients with esophageal squamous cell carcinoma and hypopharyngeal squamous cell carcinoma.
Autorzy:
Sasaki F; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. .
Mawatari S; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Oda K; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yano H; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Maeda H; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Tanaka A; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Arima S; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Kumagai K; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Tanoue S; Department of Epidemiology and Preventive Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Hashimoto S; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Kanmura S; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Ido A; Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Pokaż więcej
Źródło:
Esophagus : official journal of the Japan Esophageal Society [Esophagus] 2023 Oct; Vol. 20 (4), pp. 749-756. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/diagnosis
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Squamous Cell Carcinoma*/complications
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/etiology
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Aldehydes ; Acetaldehyde ; Ethanol
Czasopismo naukowe
Tytuł:
DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer.
Autorzy:
Katase N; Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Kudo K; Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.; Nagasaki University Dental School, Nagasaki, Japan.
Ogawa K; Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.; Nagasaki University Dental School, Nagasaki, Japan.
Sakamoto Y; Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.; Nagasaki University Dental School, Nagasaki, Japan.
Nishimatsu SI; Department of Natural Sciences, Kawasaki Medical School, Okayama, Japan.
Yamauchi A; Department of Biochemistry, Kawasaki Medical School, Okayama, Japan.
Fujita S; Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Pokaż więcej
Źródło:
Oral diseases [Oral Dis] 2023 Nov; Vol. 29 (8), pp. 3193-3204. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*
Esophageal Squamous Cell Carcinoma*
Esophageal Neoplasms*
Head and Neck Neoplasms*
Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Intercellular Signaling Peptides and Proteins/metabolism ; Squamous Cell Carcinoma of Head and Neck ; Prognosis ; Cell Proliferation ; Cell Line, Tumor ; Membrane Proteins/metabolism ; Adaptor Proteins, Signal Transducing
Czasopismo naukowe
Tytuł:
Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
Autorzy:
Chaber-Ciopinska A; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; Department of Gastroenterological Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland. />Kiprian D; Department of Head and Neck Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Wieszczy P; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; Department of Cancer Prevention, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway
Bielasik A; Department of Gastroenterological Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Bugajski M; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; Department of Gastroenterological Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Januszewicz W; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; Department of Gastroenterological Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Jarzabski A; Department of Head and Neck Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Niemiec M; Department of Head and Neck Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Mroz A; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; Department of Pathomorphology, Centre of Postgraduate Medical Education, Warsaw, Poland
Kawecki A; Department of Head and Neck Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Regula J; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; Department of Gastroenterological Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Kaminski MF; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; Department of Cancer Prevention, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Gastroenterological Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Institute of Health and Society, University of Oslo, Oslo, Norway
Pokaż więcej
Źródło:
Polish archives of internal medicine [Pol Arch Intern Med] 2023 Oct 26; Vol. 133 (10). Date of Electronic Publication: 2023 Mar 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/etiology
Esophageal Squamous Cell Carcinoma*/diagnostic imaging
Esophageal Squamous Cell Carcinoma*/chemically induced
Carcinoma, Squamous Cell*/diagnostic imaging
Head and Neck Neoplasms*
Humans ; Esophagoscopy/adverse effects ; Esophagoscopy/methods ; Squamous Cell Carcinoma of Head and Neck/chemically induced ; Coloring Agents/adverse effects ; Epithelial Cells/pathology
Czasopismo naukowe
Tytuł:
IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma.
Autorzy:
Muthupalani S; Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA, 02139, USA. .; StageBio, 5930 Main St, Mount Jackson, VA, 22842, USA. .
Annamalai D; Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA, 02139, USA.
Feng Y; Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA, 02139, USA.
Ganesan SM; Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA, 02139, USA.
Ge Z; Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA, 02139, USA.
Whary MT; Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA, 02139, USA.
Nakagawa H; Division of Digestive and Liver Diseases and Herbert Irving Cancer Research Center, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA.
Rustgi AK; Division of Digestive and Liver Diseases and Herbert Irving Cancer Research Center, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA.
Wang TC; Division of Digestive and Liver Diseases and Herbert Irving Cancer Research Center, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA.
Fox JG; Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA, 02139, USA. .; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 05; Vol. 13 (1), pp. 12732. Date of Electronic Publication: 2023 Aug 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Adenocarcinoma*/pathology
Barrett Esophagus*/pathology
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/complications
Esophageal Neoplasms*/pathology
Esophageal Squamous Cell Carcinoma*/genetics
Head and Neck Neoplasms*/complications
Mouth Neoplasms*/genetics
Mouth Neoplasms*/complications
Animals ; Child, Preschool ; Humans ; Mice ; Inflammation/genetics ; Inflammation/complications ; Metaplasia ; Mice, Transgenic ; Squamous Cell Carcinoma of Head and Neck/complications
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł:
Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
Autorzy:
Vainer G; Department of Pathology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Huang L; Department of Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, New Jersey, United States of America.
Emancipator K; Department of Translational Medicine, Merck & Co., Inc., Rahway, New Jersey, United States of America.
Nuti S; Biomarkers and Diagnostics, Oncology, Global Medical and Scientific Affairs, MRL, Merck & Co., Inc., Rahway, New Jersey, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jun 02; Vol. 18 (6), pp. e0285764. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Transitional Cell*
Urinary Bladder Neoplasms*
Triple Negative Breast Neoplasms*/diagnosis
Esophageal Neoplasms*/diagnosis
Esophageal Squamous Cell Carcinoma*
Uterine Cervical Neoplasms*/diagnosis
Head and Neck Neoplasms*/diagnosis
Lung Neoplasms*/pathology
Female ; Humans ; Immunohistochemistry ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; B7-H1 Antigen/metabolism ; Biomarkers, Tumor/metabolism ; Antibodies
Czasopismo naukowe
Tytuł:
Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma.
Autorzy:
Zhu H; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Yip HC; Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Cheung MK; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Chan HC; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Ng C; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Lau EHL; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Yeung ZWC; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Wong EWY; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Leung L; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Qu X; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Wang D; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Cai L; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Chan PKS; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Chan JYK; Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Chen Z; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2023 May 01; Vol. 152 (9), pp. 1903-1915. Date of Electronic Publication: 2023 Feb 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Esophageal Squamous Cell Carcinoma*
Esophageal Neoplasms*/microbiology
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/microbiology
Head and Neck Neoplasms*
Microbiota*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck ; Dysbiosis/complications ; RNA, Ribosomal, 16S/genetics ; Case-Control Studies ; Bacteria/genetics ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer.
Autorzy:
Xu X; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Sun Z; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu Q; Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Y; Department of Gastroenterology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen L; Department of Gastroenterology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang C; Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lin H; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hu B; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Rong L; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen H; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang X; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhao X; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Bai YR; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China .
Ye Q; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China .
Ma X; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China .
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 07; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/pathology
Carcinoma, Squamous Cell*/drug therapy
Thrombocytopenia*
Lymphopenia*
Antibodies, Monoclonal, Humanized*
Humans ; Cisplatin/therapeutic use ; Neoadjuvant Therapy ; Treatment Outcome ; Neoplasm Recurrence, Local ; Paclitaxel ; HLA-DR Antigens ; Epithelial Cells/pathology
Czasopismo naukowe
Tytuł:
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
Autorzy:
Fan C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zheng X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Sun Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Ye K; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Jiang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Xu W; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Yang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Jiang Q; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
He C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wu X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Nie X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zhang J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Tan B; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang W; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zhang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Feng Z; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Yang C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Lu Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu H; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Chen X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Xu J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu F; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zheng X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wu S; Xinyang Hospital Affiliated to Zhengzhou University & Xinyang Central Hospital, Xinyang, 464000, China.
Chen G; Xinyang Hospital Affiliated to Zhengzhou University & Xinyang Central Hospital, Xinyang, 464000, China.
Zhang Y; Anyang Cancer Hospital, Anyang, 455000, China.
Jin L; Anyang Cancer Hospital, Anyang, 455000, China.
Ge H; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 321. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/therapy
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/radiotherapy
Humans ; Consolidation Chemotherapy ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemoradiotherapy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis.
Autorzy:
Chen J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China; Soochow University Cancer Institute, Suzhou 215000, China. Electronic address: cj_.
Zhao D; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China.
Zhang L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhang J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Xiao Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Wu Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China.
Wang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China.
Zhan Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China; Soochow University Cancer Institute, Suzhou 215000, China; Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518107, China. Electronic address: .
Pokaż więcej
Źródło:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2024 Mar; Vol. 73, pp. 101055. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/metabolism
Humans ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Diacylglycerol Kinase/genetics ; Diacylglycerol Kinase/pharmacology ; Tumor-Associated Macrophages ; NADPH Oxidase 4/genetics ; Reactive Oxygen Species ; RNA, Small Interfering/genetics ; Cell Proliferation ; Chemokines/pharmacology ; Chemokines/therapeutic use ; Cell Line, Tumor ; Chemokine CCL22/pharmacology ; Chemokine CCL22/therapeutic use
Czasopismo naukowe
Tytuł:
Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway.
Autorzy:
Liang H; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Che W; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Peng F; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Chen H; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Xie X; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Wu B; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 538-549. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/metabolism
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Matrix Attachment Region Binding Proteins*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Diterpenes*
Phenanthrenes*
Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Signal Transduction ; Epoxy Compounds
Czasopismo naukowe
Tytuł:
Hsa_circ_0001707 regulates endothelial-mesenchymal transition in esophageal squamous cell carcinoma via miR-203a-3p/Snail2 pathway.
Autorzy:
Gao H; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Sun M; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Gao Z; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Song J; Institute of Nephrology, Zhongda Hospital Southeast University, Nanjing, China.
Tang D; Department of Thoracic Surgery, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, China.
Liu R; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Pokaż więcej
Źródło:
Environmental toxicology [Environ Toxicol] 2024 Mar; Vol. 39 (3), pp. 1210-1220. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/pathology
MicroRNAs*/genetics
Esophageal Neoplasms*/pathology
Humans ; RNA, Circular/genetics ; Endothelial-Mesenchymal Transition ; Cell Proliferation/genetics ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Clinical outcomes of endoscopic submucosal dissection for esophageal squamous cell carcinoma with esophageal varices: Multicenter retrospective study.
Autorzy:
Toya Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Iwate, Japan.
Hatta W; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Shimada T; Department of Gastroenterology, Sendai City Medical Center, Miyagi, Japan.
Matsuhashi T; Department of Gastroenterology and Neurology, Akita University Graduate School of Medicine, Akita, Japan.
Shiroki T; Department of Gastroenterology, Iwate Prefectural Central Hospital, Iwate, Japan.
Sasaki Y; Department of Gastroenterology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Tatsuta T; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Nakamura J; Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Hanabata N; Department of Gastroenterology, Aomori Prefectural Central Hospital, Aomori, Japan.
Horikawa Y; Department of Gastroenterology, Hiraka General Hospital, Akita, Japan.
Nagino K; Department of Gastroenterology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
Koike T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Masamune A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Harada Y; Department of Gastroenterology, Sendai City Medical Center, Miyagi, Japan.
Ohira T; Department of Gastroenterology, Sendai City Medical Center, Miyagi, Japan.
Iijima K; Department of Gastroenterology and Neurology, Akita University Graduate School of Medicine, Akita, Japan.
Abe Y; Department of Gastroenterology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Hikichi T; Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Igarashi S; Department of Gastroenterology, Aomori Prefectural Central Hospital, Aomori, Japan.
Fushimi S; Department of Gastroenterology, Hiraka General Hospital, Akita, Japan.
Takeda H; Department of Gastroenterology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
Fukuda S; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Matsumoto T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Iwate, Japan.
Pokaż więcej
Corporate Authors:
Tohoku GI Endoscopy Group
Źródło:
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society [Dig Endosc] 2024 Mar; Vol. 36 (3), pp. 314-322. Date of Electronic Publication: 2023 Jul 18.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Carcinoma, Squamous Cell*/complications
Carcinoma, Squamous Cell*/surgery
Endoscopic Mucosal Resection*/adverse effects
Endoscopic Mucosal Resection*/methods
Esophageal and Gastric Varices*/complications
Esophageal and Gastric Varices*/surgery
Esophageal Neoplasms*/complications
Esophageal Neoplasms*/surgery
Esophageal Squamous Cell Carcinoma*/complications
Esophageal Squamous Cell Carcinoma*/surgery
Humans ; Esophagoscopy/methods ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The impact of LncRNA-SOX2-OT/let-7c-3p/SKP2 Axis on head and neck squamous cell carcinoma progression: Insights from bioinformatics analysis and experimental validation.
Autorzy:
Wang D; Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, People's Republic of China.
Zhao X; Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, People's Republic of China.
Li S; Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, People's Republic of China.
Guo H; Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, People's Republic of China.
Li S; Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, People's Republic of China.
Yu D; Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło:
Cellular signalling [Cell Signal] 2024 Mar; Vol. 115, pp. 111018. Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Squamous Cell Carcinoma of Head and Neck*/genetics
Squamous Cell Carcinoma of Head and Neck*/secondary
Animals ; Humans ; Mice ; Computational Biology ; Gene Expression Regulation, Neoplastic ; Lung Neoplasms/secondary ; RNA, Messenger/metabolism ; SOXB1 Transcription Factors/genetics ; SOXB1 Transcription Factors/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Camrelizumab in combination with neoadjuvant chemotherapy in resectable locally advanced esophageal squamous carcinoma cancer: Results from a retrospective study.
Autorzy:
Kang NN; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Zheng H; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Hu JX; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Cui K; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Si PP; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Ge W; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Pokaż więcej
Źródło:
The Kaohsiung journal of medical sciences [Kaohsiung J Med Sci] 2024 Mar; Vol. 40 (3), pp. 291-295. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/surgery
Carcinoma*
Antibodies, Monoclonal, Humanized*
Humans ; Neoadjuvant Therapy ; Retrospective Studies ; Vomiting ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Neoadjuvant Radiochemotherapy Alters the Immune and Metabolic Microenvironment in Oral Cancer-Analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α Expressions.
Autorzy:
Weber M; Department of Oral and Cranio-Maxillofacial Surgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054 Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Ries J; Department of Oral and Cranio-Maxillofacial Surgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054 Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Braun K; Department of Oral and Cranio-Maxillofacial Surgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054 Erlangen, Germany.
Wehrhan F; Department of Oral and Cranio-Maxillofacial Surgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054 Erlangen, Germany.; Private Office for Maxillofacial Surgery, 09599 Freiberg, Germany.
Distel L; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Geppert C; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Lutz R; Department of Oral and Cranio-Maxillofacial Surgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054 Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Kesting M; Department of Oral and Cranio-Maxillofacial Surgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054 Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Trumet L; Department of Oral and Cranio-Maxillofacial Surgery, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054 Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Department of Operative Dentistry and Periodontology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 25; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:
Journal Article
MeSH Terms:
Mouth Neoplasms*/therapy
Squamous Cell Carcinoma of Head and Neck*/therapy
Humans ; Cisplatin ; Hypoxia/metabolism ; Neoadjuvant Therapy ; Retrospective Studies ; Transforming Growth Factor beta1 ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
SENP3 mediates the activation of the Wnt/β-catenin signaling pathway to accelerate the growth and metastasis of oesophagal squamous cell carcinoma in mice.
Autorzy:
Wang P; Department of Thoracic Surgery, the Fourth Hospital of Hebei Medical University, No.12 Jian-Kang Road, Chang-An District, Shijiazhuang, 050011, People's Republic of China.
Yang L; Department of Respiratory Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China.
Guo Y; Department of Radiotherapy, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China.
Qi S; Department of Thoracic Surgery, Gucheng County Hospital in Hebei Province, Hengshui, 253800, People's Republic of China.
Liang J; Department of Cancer, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China.
Tian G; Medical Record Room, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China.
Tian Z; Department of Thoracic Surgery, the Fourth Hospital of Hebei Medical University, No.12 Jian-Kang Road, Chang-An District, Shijiazhuang, 050011, People's Republic of China. dr_.
Pokaż więcej
Źródło:
Functional & integrative genomics [Funct Integr Genomics] 2024 Feb 22; Vol. 24 (2), pp. 40. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/metabolism
Esophageal Neoplasms*/genetics
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/metabolism
Esophageal Squamous Cell Carcinoma*/pathology
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cysteine Endopeptidases/genetics ; Cysteine Endopeptidases/metabolism ; Gene Expression Regulation, Neoplastic ; Wnt Signaling Pathway/genetics
Czasopismo naukowe
Tytuł:
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
Autorzy:
Jakstas T; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania. .
Bartnykaite A; Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Padervinskis E; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Vegiene A; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Juozaityte E; Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Uloza V; Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Ugenskiene R; Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.; Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 15; Vol. 24 (1), pp. 214. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
E2F1 Transcription Factor*/genetics
E2F2 Transcription Factor*/genetics
Laryngeal Neoplasms*/genetics
Laryngeal Neoplasms*/pathology
Squamous Cell Carcinoma of Head and Neck*/genetics
Squamous Cell Carcinoma of Head and Neck*/pathology
Humans ; Polymorphism, Single Nucleotide ; Prognosis
Czasopismo naukowe
Tytuł:
Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
Autorzy:
Lu RD; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Wei ZD; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Liu YX; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Tian D; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Zhang HL; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Shang QX; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Hu WP; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Yang L; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China.
Yang YS; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China. .
Chen LQ; Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, 610041, Chengdu, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 05; Vol. 24 (1), pp. 177. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/surgery
Carcinoma, Squamous Cell*/surgery
Humans ; Cohort Studies ; Prognosis ; Lymph Node Excision ; Lymph Nodes/surgery ; Lymph Nodes/pathology ; Neoadjuvant Therapy ; Esophagectomy ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Applying Untargeted Lipidomics to Evaluate the Efficacy of Combined Neoadjuvant Chemotherapy and Immunotherapy for Esophageal Squamous Carcinoma Treatment.
Autorzy:
Lin W; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Si X; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Zhao Z; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Chen F; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Xu J; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Huang W; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Lin J; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Chen Z; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Huang Z; Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Pokaż więcej
Źródło:
Journal of proteome research [J Proteome Res] 2024 Feb 02; Vol. 23 (2), pp. 663-672. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/pathology
Carcinoma, Squamous Cell*/drug therapy
Humans ; Neoadjuvant Therapy/methods ; Treatment Outcome ; Lipidomics ; Chemotherapy, Adjuvant ; Esophagectomy/methods ; Immunotherapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies